"Neuromod secures €10m to expand tinnitus treatment device’s availability" was originally created and published by Medical ...
Neuromod Devices announced today that it closed an equity financing round worth proceeds of about $10.9 million (€10 million) ...
Neuromod Devices Ltd. raised €10 million (US$10.9 million) in financing to expand the reach of Lenire, which treats tinnitus.
Irish medtech group Neuromod Devices has raised €10 million equity financing to expand the availability of its tinnitus ...
Irish medtech company Neuromod has raised €10m in equity financing to expand the production of Lenire – a device that helps ...
DUBLIN, March 11, 2025 /PRNewswire/ -- Neuromod Devices Ltd. (Neuromod), an Irish medical device company specialising in tinnitus, has successfully closed a €10 million equity financing to ...
Dublin-based company has developed an FDA-approved device called Lenire that is for use with patients suffering from tinnitus ...
The financing was oversubscribed and was led by existing investors Fountain Healthcare Partners and Panakès Partners, backing Neuromod's mission to advance tinnitus care for patients globally.